Samantha Blons
About Samantha Blons
Samantha Blons is Secretary of ChampionX Corporation and, following the July 16, 2025 closing of the SLB–ChampionX merger, became a director of the Surviving Corporation alongside Paul Sims and Matthias Abrell . Prior to this, she served on SLB’s in‑house legal team as Senior Corporate Legal Counsel, actively participating in the ChampionX acquisition process and frequently signing SLB insider filings as attorney‑in‑fact . For performance context, ChampionX delivered FY2024 revenue of $3,633.983 million and net income of $320.266 million , with Annual TSR at -5.6% in 2024 after strong gains in prior years .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| SLB (Schlumberger Limited) | Senior Corporate Legal Counsel | 2024 | In‑house legal lead team for acquisition of ChampionX; cross‑functional deal execution support . |
| SLB | Attorney‑in‑fact for SEC insider filings | 2022–2025 | Supported executive Form 4 filings, signaling governance and disclosure oversight . |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| ChampionX Surviving Corporation | Director | 2025–present | Appointed at merger Effective Time with Merger Sub directors; post‑merger subsidiary governance . |
Fixed Compensation
- Not disclosed. Samantha Blons is not listed as a Named Executive Officer (NEO) in ChampionX’s FY2024 proxy; NEOs were Somasundaram, Fisher, Bryant, Mahoney, and Wright . Employee directors generally do not receive additional board compensation under ChampionX policy .
Performance Compensation
- Not disclosed for Blons individually. For context, ChampionX’s executive program emphasizes:
- Annual cash incentives tied to operational/financial measures and strategic goals .
- Long‑term incentives split between RSUs (time‑based, three-year ratable vesting) and PSAs (three-year cliff, metrics: relative TSR vs peer group and free cash flow as % of revenue; absolute TSR collar limits payouts) .
- 2024 LTIP targets (for NEOs) reflected 50% RSUs/50% PSAs; example NEO targets shown (e.g., CEO $2.625M RSUs/$2.625M PSAs) .
PSA Metric Design (Company framework)
| Metric | Weighting | Target | Payout Curve | Vesting |
|---|---|---|---|---|
| Relative TSR vs TSR Peer Group | 50% of PSAs (effective) | 50th percentile = 100% | 0% below 25th; 25% at 25th; 200% at/above 90th; capped at 100% if absolute TSR negative; floor ≥50% if annualized absolute TSR >15% | Three-year cliff . |
| Free Cash Flow as % of Revenue | 50% of PSAs (effective) | 7.0% = 100% | 50% at 4.5% threshold; 200% at ≥10.5%; linear interpolation | Three-year cliff . |
Equity Ownership & Alignment
- Total beneficial ownership, vested/unvested, and options for Blons: not disclosed.
- Company policies:
- Executive stock ownership guidelines: CEO 5x salary; Section 16 officers 3x; other corporate officers 2x; five years to comply; RSUs count .
- Anti‑hedging/anti‑pledging policy for directors and officers .
- Clawback policy aligned with Nasdaq Rule 10D (three‑year lookback) .
Employment Terms
- Office: Secretary of ChampionX; signed multiple 2025 SEC filings (8‑K, S‑8 POS amendments, Form 15) in that capacity .
- Appointment timing: Effective Time of July 16, 2025 merger; prior officers ceased; new leadership installed (President Paul Sims) .
- Severance/change‑of‑control: Not disclosed for Blons; Company adopted 280G mitigation agreements for certain executive officers (e.g., CFO Fisher) ahead of merger .
- Non‑compete/non‑solicit/garden leave/consulting: Not disclosed.
Board Governance
- Board service: Became director of the Surviving Corporation at merger close, replacing pre‑merger public Board; pre‑merger CHX independent Board and committees resigned at Effective Time .
- Committee roles: Not disclosed for post‑merger subsidiary Board. Pre‑merger, Audit/Compensation/Governance committees were fully independent and chaired by seasoned directors .
- Independence: As an officer (Secretary) and director, Blons is not independent under typical Nasdaq/SEC definitions; pre‑merger public Board required independence for committee membership . Employee directors did not receive board compensation .
- Executive sessions: Pre‑merger public Board held regular executive sessions; governance highlights included robust succession planning, ownership guidelines, and anti‑pledging .
Director Compensation
- Not applicable to Blons pre‑merger (not a director). For context, pre‑merger FY2024 non‑employee director pay: $240,000 annual retainer ($112,500 cash/$127,500 equity), plus chair and committee retainers; five‑times cash retainer ownership guideline; deferral available via DSUs; employee directors receive no extra board compensation .
Performance & Track Record (Company Context)
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Annual TSR (%) | -54.7% | 32.1% | 44.6% | 1.9% | -5.6% |
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Revenue ($USD Thousands) | 3,805,948 | 3,758,285 | 3,633,983 |
| Net Income attributable to ChampionX ($USD Thousands) | 154,969 | 314,238 | 320,266 |
Risk Indicators & Red Flags
- Hedging/pledging: Prohibited by policy (limited exceptions) for directors and officers .
- Related party transactions: None required to be reported for 2023; approval procedures in place .
- Legal proceedings/SEC investigations for Blons: Not disclosed.
- Governance transition risk: Post‑merger change‑of‑control led to wholesale Board/officer changes; subsidiary governance may reduce public transparency .
Compensation Peer Group & Say‑on‑Pay (Company Context)
- Company’s long‑term PSAs use a distinct TSR peer group (includes BKR, HAL, SLB, NOV, Cabot, Chemours, Olin, etc.), separate from compensation peer sets, to align long‑term growth incentives .
- Pay‑versus‑performance highlights: Annual TSR designated as most important financial measure; also uses adjusted EBITDA and adjusted free cash flow .
- Say‑on‑Pay conducted for NEOs in 2025 proxy; Board recommended FOR .
Equity Trading & Filings (2025 Merger Close)
- CHX filed delisting and deregistration post‑close; Form 15 signed by Blons as Secretary; CHX common converted into SLB shares at 0.735 exchange ratio .
Investment Implications
- Alignment: As Secretary and director of the post‑merger Surviving Corporation, Blons is a governance operator rather than an incentive‑compensated NEO; individual pay/ownership data are not disclosed, limiting direct pay‑for‑performance assessment for her role .
- Retention risk: Her deep involvement with SLB’s legal function and leadership in the ChampionX acquisition suggests strong integration with SLB’s governance—low near‑term retention risk signals but reduced visibility due to subsidiary status .
- Trading signals: Absence of Form 4 activity by Blons as a reporting person and anti‑hedging/anti‑pledging policies reduce concern about near‑term insider selling pressure tied to her role; broader CHX/SLB equity dynamics post‑exchange drive investor outcomes .
- Governance considerations: Dual role as officer and director typically raises independence considerations; however, post‑merger subsidiary governance may not mirror public board independence requirements, implying decisions are more closely aligned with SLB strategy .